Cannabis Investment Report – Global Regulatory Overview (Dec 2017)
Cannabis Investment Report – Global Regulatory Overview (Dec 2017) The passage provides a general summary of cannabis regulations in various countries and mentions a specific pharmaceutical company (GW Pharmaceuticals) and a licensing event in Lesotho, but it lacks concrete leads linking high‑level officials, financial transactions, or misconduct. The information is largely public and already known, offering minimal investigative value. Key insights: Greece permits cannabis extracts for specific medical conditions.; UK Home Office licenses GW Pharmaceuticals for medical cannabis production (Sativex).; South Africa's drug law sections declared unconstitutional in 2017.
Summary
Cannabis Investment Report – Global Regulatory Overview (Dec 2017) The passage provides a general summary of cannabis regulations in various countries and mentions a specific pharmaceutical company (GW Pharmaceuticals) and a licensing event in Lesotho, but it lacks concrete leads linking high‑level officials, financial transactions, or misconduct. The information is largely public and already known, offering minimal investigative value. Key insights: Greece permits cannabis extracts for specific medical conditions.; UK Home Office licenses GW Pharmaceuticals for medical cannabis production (Sativex).; South Africa's drug law sections declared unconstitutional in 2017.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.